Richard Brudnick

Mr. Richard H.
Brudnick is an Independent Director at Scholar Rock Holding Corp., a Chief Business Officer at Prime Medicine, Inc., an Independent Director at Volition America, Inc., an Independent Non-Executive Director at InflaRx NV and a Venture Advisor at Israel Biotech Fund.
He is on the Board of Directors at Scholar Rock Holding Corp., Volition America, Inc. and InflaRx NV.
Mr. Brudnick was previously employed as an Independent Director by VolitionRX Ltd., a Chief Business Officer & Head-Strategy by Codiak BioSciences, Inc., an Executive Vice President-Business Development by Bioverativ, Inc., a Senior VP-Corporate Development & Strategy by Biogen, Inc., and a President & Chief Executive Officer by James Brudnick Co., Inc. He also served on the board at Tamarix Pharma Ltd. He received his undergraduate degree from Massachusetts Institute of Technology, an undergraduate degree from MIT Sloan School of Management, a graduate degree from MIT Sloan School of Management and an MBA from MIT Sloan School of Management.